Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-02-27 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
代本公司重要子公司中化裕民健康事業股份有限公司 公告其董事會決議不發放113年度股利
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company (3716 中化控股) regarding a board resolution of its important subsidiary not to distribute dividends for the fiscal year 113. The key phrase is '董事會決議不發放113年度股利' which translates to 'board resolution not to distribute dividends for fiscal year 113.' This is a clear announcement about dividend decisions. The document length is very short (503 characters), and it is not a full report but a notification of a dividend decision. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-02-27 Chinese
公告本公司113年度財務報告董事會預計召開日期為 114年3月6日
Report Publication Announcement Classification · 95% confidence The document is a short announcement (544 characters) from a company (3716 中化控股) stating the planned date for the board meeting to discuss the 113th fiscal year financial report. It does not contain the financial report itself but announces the meeting date and the intention to present the annual consolidated financial report. The document is essentially a notification about an upcoming report or meeting, not the report itself. According to the 'MENU VS MEAL' rule, such short announcements about report timing or meetings are classified as Report Publication Announcements (RPA).
2025-02-26 Chinese
公告本公司第1次買回庫藏股期間屆滿及執行情形
Transaction in Own Shares Classification · 100% confidence The document is a company announcement regarding the completion and details of a share buyback program (treasury stock repurchase). It includes specifics such as the total amount authorized, the period, number of shares repurchased, average price, and cumulative shares held. This type of document is a report of the company buying back its own shares, which fits the category 'Transaction in Own Shares' (POS). The document is short and focused solely on the buyback execution details, not a broader financial report or announcement of a report publication.
2025-02-26 Chinese
功能性委員會成員
Board/Management Information Classification · 90% confidence The document is very short (233 characters) and contains a table with company code, name, establishment date, and member list with expertise. It appears to be a basic disclosure of board or committee members and their qualifications. There is no financial data, no report or announcement of voting results, no mention of meetings or financial performance. It is not a report or announcement of a report. The content fits best with Board/Management Information (MANG) as it relates to company members and their roles.
2025-02-17 Chinese
114年1月營業收入
Regulatory Filings Classification · 95% confidence The document is very short (565 characters) and consists mainly of a summary table listing company codes and names, with a note about monthly revenue reporting by subsidiaries. There is no detailed financial data, no mention of a specific report, no regulatory certification, or any announcement of voting results, management changes, or legal proceedings. The content appears to be a general regulatory or informational filing without substantive financial or corporate event details. Given the lack of specific report content and the nature of the information, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2025-02-10 Chinese
114年1月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document is a financial disclosure from a listed company (中化控股) providing details on fund loans and endorsement guarantees for the current and previous month, including limits and balances. It is a short document (631 characters) and contains tabular financial data related to internal financing and guarantees. There is no indication that this is a full annual or interim report, nor is it an announcement of a report publication. The content is specific to capital and financing activities, such as loans and guarantees, which aligns with updates on financing activities or capital structure changes. Therefore, the document best fits the category of Capital/Financing Update (CAP).
2025-02-10 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.